PIQRAY is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Novartis Pharmaceuticals Corporation. The primary component is Alpelisib.
Product ID | 0078-0708_0966a539-f6fd-4cab-9d30-152f48583edd |
NDC | 0078-0708 |
Product Type | Human Prescription Drug |
Proprietary Name | PIQRAY |
Generic Name | Alpelisib |
Dosage Form | Tablet |
Route of Administration | ORAL |
Marketing Start Date | 2019-05-24 |
Marketing Category | NDA / NDA |
Application Number | NDA212526 |
Labeler Name | Novartis Pharmaceuticals Corporation |
Substance Name | ALPELISIB |
Active Ingredient Strength | 150 mg/1 |
NDC Exclude Flag | N |
Listing Certified Through | 2022-12-31 |
Marketing Start Date | 2019-05-24 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA212526 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-24 |
Marketing Category | NDA |
Application Number | NDA212526 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2019-05-24 |
Marketing Category | NDA |
Application Number | NDA212526 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2019-05-24 |
Marketing Category | NDA |
Application Number | NDA212526 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-24 |
Ingredient | Strength |
---|---|
ALPELISIB | 150 mg/1 |
SPL SET ID: | b20b4e18-7a4b-4500-a08f-06c6dab0ee5b |
Manufacturer | |
UNII |
NDC | Brand Name | Generic Name |
---|---|---|
0078-0701 | PIQRAY | alpelisib |
0078-0708 | PIQRAY | alpelisib |
0078-0715 | PIQRAY | alpelisib |
0078-1021 | VIJOICE | alpelisib |
0078-1028 | VIJOICE | alpelisib |
0078-1035 | VIJOICE | alpelisib |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
PIQRAY 86279420 not registered Dead/Abandoned |
Novartis AG 2014-05-13 |
PIQRAY 79219218 5415224 Live/Registered |
NOVARTIS AG 2017-08-23 |